14 CBD Statistics on Market Growth, Use, and Product Trust

CBD moved from a niche supplement to a mainstream category in under a decade, and the numbers behind that shift are worth knowing before you buy. If you are still sorting out what CBD is, the short version is that cannabidiol is non-intoxicating, which is a large part of why adoption spread so fast. Roughly 14% of Americans already use it. The statistics below show how big the market has become, who is buying, why they say they use it, and where product quality still falls short.

1. The U.S. CBD market reached an estimated $4 billion

Brightfield Group valued the U.S. CBD market at about $4 billion in 2019, up sharply after hemp-derived CBD was federally legalized in the 2018 Farm Bill. That legalization is the single largest driver of the category's scale, because it opened nationwide retail and online sales.

2. Forecasts put the market at $25 billion by 2025

Brightfield Group projected U.S. CBD sales to climb to roughly $25 billion by 2025, a more than sixfold increase from 2019. Even partial progress toward that figure represents one of the fastest expansions in the supplement space.

3. Analysts modeled a 49% annual growth rate

Market researcher BDSA estimated the category would grow at a compound annual rate near 49% through 2024. Growth at that pace is what turned CBD from a specialty item into a fixture on pharmacy and grocery shelves.

4. 14% of Americans currently use CBD products

A national Gallup poll found that 14% of U.S. adults, close to 1 in 7, report using CBD. That level of reach puts CBD ahead of many longer-established supplements.

5. A third of adults have tried CBD at least once

Survey data shows 33% of American adults have used CBD one or more times, well above the share who use it regularly. The gap between trial and routine use points to a large pool of occasional buyers.

6. 64% of Americans are familiar with CBD

Awareness now far outpaces usage, with 64% of Americans familiar with CBD products even if they have not bought any. High awareness paired with lower trial signals real room for first-time buyers.

7. An estimated 64 million Americans tried CBD in two years

A Consumer Reports analysis estimated that about 64 million Americans had used CBD in the prior 24 months. Numbers at that scale explain why mainstream retailers added CBD lines so quickly.

8. Pain is the most common reported reason

Among CBD users, 64% say they use it for pain. These figures reflect why people say they reach for CBD, not medical claims about what it does.

9. Anxiety ranks second among stated reasons

Just under half of users, 49%, report using CBD for anxiety. It is one of the most common reasons given across every product format.

10. Insomnia is a leading use case

42% of users say they take CBD for insomnia, making sleep the third most cited reason. Demand for nighttime formats follows directly from that pattern.

11. 20% of adults under 30 use CBD

CBD use concentrates among younger adults, with 20% of those under 30 reporting use. Familiarity with cannabis broadly tracks with willingness to try CBD specifically, and that comfort is highest in younger groups.

12. Usage declines steadily with age

Gallup found regular use falls from 16% among adults 30 to 49 to 11% among those 50 to 64 and 8% among adults 65 and older. Older buyers remain a smaller share today, though wellness formats are bringing more of them in.

13. Oils, balms, and gummies are the favored formats

Buyers gravitate toward a handful of formats, with oils and tinctures, lotions and balms, and gummies leading the way. Sublingual tinctures stay popular because they let users control servings precisely, while gummies win on convenience.

14. Nearly 70% of online CBD products were mislabeled

A study covered by SingleCare found that close to 70% of CBD products sold online were mislabeled for CBD content, with some containing undisclosed THC. This single statistic is the strongest argument for buying only products that publish a current certificate of analysis, the same standard we hold ourselves to in our verification process.

The data tells a consistent story. Demand is large and durable, usage is mainstream rather than fringe, and the main risk is not the category itself but inconsistent product quality. For buyers, that turns a few habits into non-negotiables:

• Check the certificate of analysis. Confirm CBD content and THC levels with a recent lab report before buying.
• Match the format to the use case. Tinctures for serving control, gummies for convenience, topicals for a targeted area.
• Read the label for source and serving. Hemp-derived status, total CBD per serving, and a batch number should all be visible.
• Read reasons-for-use as reported. Survey figures reflect why people say they use CBD, not medical outcomes, and CBD differs from intoxicating cannabis strains and from state cannabis laws that govern THC.

How many people use CBD?

About 14% of U.S. adults, roughly 1 in 7, report using CBD products, and 33% have tried it at least once. Usage is highest among adults under 30, at 20%, and declines in each older age group.

Why do most people say they use CBD?

Surveys rank pain (64%), anxiety (49%), and insomnia (42%) as the most common self-reported reasons. These are reasons people give for use, not medical claims, and almost no users report taking CBD to feel intoxicated, since cannabidiol is non-intoxicating.

Is CBD product labeling reliable?

Not always. A study reported by SingleCare found close to 70% of online CBD products were mislabeled, and some contained undisclosed THC. The most reliable safeguard is buying products that publish a current third-party certificate of analysis.

How big is the CBD market?

U.S. CBD sales were estimated at $4 billion in 2019 and projected to reach $25 billion by 2025, with analysts modeling annual growth near 49%. That makes CBD one of the fastest-scaling categories in the supplement market.